國家衛生研究院 NHRI:Item 3990099045/11053
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857826      線上人數 : 835
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11053


    題名: The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors
    作者: Tsai, HJ;Chu, PY;Jiang, SS;Shan, YS;Hung, WC;Chen, MH;Lin, HY;Chen, YL;Chen, LT
    貢獻者: National Institute of Cancer Research
    摘要: Pancreatic neuroendocrine tumor (pNET) is a rare type of pancreatic cancer. Agents targeting angiogenesis and mTOR, sunitinib and everolimus, have been shown to prolong the progression free survival by around 11 months for pNET patients. To further improve the survival of pNET, a novel treatment is needed. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M), which is encoded by PCK2, was demonstrated to play a critical role in the survival program initiated upon stress in cancer metabolism. Although elevated expression of PCK2 has been found in various tumors, the role of PEPCK-M aberration in cancers is not well understood. In our study, 12 of 21 pNET patients had high expression of PEPCK-M in the tumors. Knockdown of PCK2 inhibited the proliferation of pNET cells and enhanced the sensitivity of pNET cells to mTOR inhibitors. Knockdown of PCK2 promoted glycolysis but reduced mitochondrial oxidative phosphorylation of pNET cells. Combination of mTOR inhibitors and anti-glycolysis agent synergistically inhibited the proliferation of pNET cells. Therefore targeting PEPCK-M or glycolysis combined with mTOR inhibitors is a potential therapeutic approach for the treatment of pNET.
    日期: 2018-01
    關聯: Cancer Science. 2018 Jan;109(Suppl. 1):466.
    Link to: http://dx.doi.org/10.1111/cas.13499
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000422694003154
    顯示於類別:[蔡慧珍] 會議論文/會議摘要
    [陳立宗] 會議論文/會議摘要
    [洪文俊] 會議論文/會議摘要
    [江士昇] 會議論文/會議摘要

    文件中的檔案:

    檔案 大小格式瀏覽次數
    ISI000422694003154.pdf48KbAdobe PDF313檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋